Neuren Pharmaceuticals LimitedASX: NEU

Trofinetide accepted for Priority Review by Health Canada

Apr 23, 2024 at 4:03 AM UTC · Issued by Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Ltd has released a press release.

View Attachment